Juul Lawsuit Update October 2026: $1.7 Billion in Settlements, 11 Cases Left & Your Options Now
The Juul litigation is nearly over: roughly $1.7 billion in settlements paid, the class action closed in February 2024, and only 11 of 7,071 cases remained pending as of September 2026. If Juul harmed you and you never filed, a personal injury claim may still be open.
- Key facts: the multidistrict litigation (MDL 2913) was consolidated before Judge William H. Orrick III in the Northern District of California on October 2, 2019.
- Roughly $1.7 billion has been paid across settlements with school districts, local governments, and individual plaintiffs.
- The consumer class action fund totaled about $300 million and closed to new claims on February 5, 2024 — it covered economic harm, not personal injury.
- Only 11 of 7,071 cases remained pending as of September 1, 2026, with a separate antitrust trial over pod price-fixing set for September 28, 2026.
- Personal injury cases ran on a separate track from the class action, and the window for new individual claims has not fully closed.
How $1.7 Billion Changed the Landscape
At the center stands MDL 2913 — a multidistrict litigation, which is a procedure that gathers hundreds of similar federal lawsuits before one judge for coordinated pretrial proceedings. Judge William H. Orrick III has overseen it since consolidation on October 2, 2019.
What makes this litigation unusual is its speed. Within three years came the first major nationwide settlement: on December 6, 2022, an agreement covering more than 5,000 cases filed by roughly 10,000 plaintiffs.
The Class Action: $300 Million for Overpaying Consumers
A class action is a lawsuit in which one group of plaintiffs represents a much larger class of people who suffered the same harm. In the Juul case, the consumer class action covered people who bought Juul products in the United States on or before December 7, 2022. The legal theory was economic harm: consumers argued they overpaid because Juul misrepresented addictiveness and marketed to minors.
The fund totaled approximately $300 million — $255 million from Juul and $45.5 million from Altria. Initial payments ran from October 18, 2024 through May 30, 2025: 843,451 approved claimants, of whom 733,055 cashed their payments. A second round began March 20, 2026, distributing the remaining $15.37 million to 165,982 eligible claimants. Crucially, this fund closed to new claims on February 5, 2024.
Altria and the States: The Other Settlements That Made Up $1.7 Billion
Beyond the consumer fund, the biggest checks went to governments and injured people. On May 10, 2023, Altria agreed to pay $235 million to resolve at least 6,000 state and federal cases — about 50 economic class actions, some 4,500 personal injury actions, and roughly 1,500 government-entity actions, of which about 1,400 were brought by school districts. A month earlier, in April 2023, a $462 million settlement with six U.S. states closed out the youth-marketing claims.
It is a textbook example of mass torts resolving in waves — separate tracks for consumers, governments, and injured people. Our explainer on mass torts versus class actions walks through exactly these mechanics.
The Youth-Marketing Evidence That Started It All
It is worth remembering why plaintiffs had such strong claims. In September 2019, the FDA warned Juul after a company representative reportedly told students the product was "99% safer" than cigarettes — a claim the agency said Juul had no authorization to make. Sleek products, flavors and marketing that appealed to teenagers, and potent nicotine formulations: that factual foundation sits beneath the entire $1.7 billion.
Personal Injury Claims: The Separate Track That Still Matters
Here is the distinction that matters most in October 2026. Personal injury claims — lung damage, addiction, seizures, or other health problems — ran on a separate track from the class action, which compensated only economic harm. It did not compensate injury. Thousands of personal injury cases were part of the December 2022 settlement block, but cases that were never filed are a different story.
If you suffered serious health effects and never joined the litigation, an individual claim may still be open to you. Statutes of limitations vary by state, and some have expired — but not all, particularly where the injury was discovered recently. One caution: compensation varies widely by case, and most settlements are confidential.
11 Cases Left: What the Tail End Looks Like
As of September 1, 2026, only 11 of the 7,071 cases filed since the litigation began were still pending. The remaining work includes a separate antitrust class action (N.D. California case 3:20-cv-02345) alleging Juul and Altria conspired to fix pod prices. Trial is set September 28, 2026, with no settlement yet — the last unresolved one.
The same dynamics — disputed safety claims, billions at stake, waves of claimants — are visible in the talc powder litigation and the Ozempic lawsuits.
Your Options Now: A Clear Decision Guide
First, the consumer class action: closed. No new claims; the second round of payments is already underway. Second, personal injury claims: this is the live track. If you experienced lung damage, severe nicotine addiction, seizures, or other documented health problems linked to Juul use, speak with a product-liability attorney promptly — deadlines are state-specific.
Third, keep expectations realistic. The documented aggregates — the $300 million class fund, the $235 million Altria resolution, the $462 million state settlement — are program totals, not per-person guarantees. A firm promising a specific payout is waving a red flag. For plain-language coverage of product-liability developments, see Problem Solved.
Who Benefits From This — and Who Does Not
Roughly $1.7 billion has been paid across the Juul settlements, the consumer class action closed to new claims on February 5, 2024, and only 11 of 7,071 cases remained pending as of September 2026 — so this guide is most useful to readers who can still act on a separate track, and least useful to anyone hoping to join a closed fund.
Who benefits:
- People with a personal injury claim who never filed — personal injury cases ran on a separate track from the class action and compensate physical harm such as lung damage or addiction; statutes of limitations differ by state and by when the injury was discovered, so a product-liability attorney can tell you in a free consultation whether your claim is still viable.
- Readers tracking the last unresolved piece — the separate antitrust class action (case 3:20-cv-02345) has a trial date of September 28, 2026, and no settlement has been reached.
- People who already filed and want the current picture — with only 11 cases left pending, this update explains where the litigation stands now.
Who does not benefit:
- Anyone hoping to join the consumer class action now — it closed on February 5, 2024, initial payments went out between October 2024 and May 2025, and a second round began in March 2026; the class action cannot accept a new claim.
- Anyone expecting a reliable average payout figure — there is no reliable published per-claimant average: the $300 million fund paid 843,451 approved claimants, with individual amounts depending on documented purchases.
- Anyone whose personal injury deadline has already passed in their state — some deadlines have passed while others remain open, so only a case-by-case attorney review can answer that question.
Related reading: Medtronic Bravo Capsule Recall 2026.
Frequently Asked Questions
Can I still join the Juul class action?
No. The consumer class action closed to new claims on February 5, 2024. Initial payments went out between October 2024 and May 2025, and a second round began in March 2026. If you missed the deadline, the class action cannot accept your claim.
What is the difference between the class action and a personal injury case?
The class action compensated economic harm — consumers who overpaid for Juul products because of alleged misrepresentation. Personal injury cases, which ran on a separate track, compensate actual physical harm such as lung damage or addiction. The class action being closed does not automatically bar a personal injury claim.
How much did the average claimant get from the $300 million fund?
There is no reliable published per-claimant average. The fund paid 843,451 approved claimants, with 733,055 cashing payments and a $15.37 million second round in 2026. Individual amounts depended on documented purchases.
Is it too late to file a personal injury lawsuit over Juul?
Not necessarily. Statutes of limitations differ by state and by when the injury was discovered, so some deadlines have passed while others remain open. A product-liability attorney can tell you in a free consultation whether your claim is still viable.
What is happening with the Juul antitrust case?
A separate antitrust class action (case 3:20-cv-02345 in the Northern District of California) alleges Juul and Altria fixed pod prices. It has a trial date of September 28, 2026, and no settlement has been reached — it is the last major unresolved piece of the Juul litigation.
Who can still benefit from the Juul litigation?
People with a personal injury claim — physical harm such as lung damage or addiction — may still benefit, because personal injury cases ran on a separate track from the consumer class action and the window for new individual claims has not fully closed. The consumer class action itself cannot help new joiners: it closed to new claims on February 5, 2024. A product-liability attorney can tell you in a free consultation whether your claim is still viable.
This article is general information, not legal advice; consult a licensed attorney about your situation.